172 related articles for article (PubMed ID: 9087871)
1. Evaluation of tetrahydropyranyladriamycin as an immunosuppressant in concordant xenotransplantation.
Yasutomi M; Hayashi S; Ito M; Ohtsuka S; Namii Y; Uchida K; Yokoyama I; Takagi H
J Heart Lung Transplant; 1997 Mar; 16(3):283-9. PubMed ID: 9087871
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a concordant xenogeneic splenocyte injection model for the dynamic study of the marginal zone in the spleen.
Yasutomi M; Ito M; Hayashi S; Ohtsuka S; Namii Y; Uchida K; Yokoyama I; Takagi H
J Heart Lung Transplant; 1998 May; 17(5):452-9. PubMed ID: 9628563
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydropyranyladriamycin with FK 506 combination therapy for hamster-to-rat-concordant xenotransplantation.
Namii Y; Yasutomi M; Hayashi S; Ito M; Ohtsuka S; Uchida K; Yokoyama I; Takagi H
Transplant Proc; 1996 Apr; 28(2):709-10. PubMed ID: 8623358
[No Abstract] [Full Text] [Related]
4. Effect of tetrahydropyranyladriamycin on concordant xenotransplantation in the splenocyte injection and heart transplantation model.
Yasutomi M; Hayashi S; Ohtsuka S; Namii Y; Ito M; Uchida K; Yokoyama I; Takagi H
Transplant Proc; 1995 Apr; 27(2):1628-9. PubMed ID: 7725429
[No Abstract] [Full Text] [Related]
5. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
Langer A; Valdivia LA; Murase N; Woo J; Celli S; Fung JJ; Starzl TE; Demetris AJ
Am J Pathol; 1993 Jul; 143(1):85-98. PubMed ID: 7686346
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cardiac rejection in heart and heart-lung concordant xenotransplantation.
Yoshida Y; Kitamura S; Kawachi K; Taniguchi S; Kondo Y
J Heart Lung Transplant; 1994; 13(2):325-31. PubMed ID: 7518252
[TBL] [Abstract][Full Text] [Related]
7. Evidence that donor pretreatment with FK506 has a synergistic effect on graft prolongation in hamster-to-rat heart xenotransplantation.
Hayashi S; Ito M; Yasutomi M; Namii Y; Yokoyama I; Uchida K; Takagi H
J Heart Lung Transplant; 1995; 14(3):579-84. PubMed ID: 7544621
[TBL] [Abstract][Full Text] [Related]
8. Prolonged survival of hamster-to-rat pulmonary xenografts by tacrolimus (FK506) and cyclophosphamide.
Komatsu K; Youm W; Konishi H; Kawaharada N; Yousem SA; Murase N; Griffith BP; Pham SM
J Heart Lung Transplant; 1996 Jul; 15(7):722-7. PubMed ID: 8820789
[TBL] [Abstract][Full Text] [Related]
9. The role of graft and host accommodation in a hamster-to-rat cardiac transplantation model.
Komori K; Fuchimoto Y; Morikawa Y; Obara H; Kawachi S; Tanabe M; Hoshino K; Shimazu M; Matsuzaki Y; Kitajima M
Transplantation; 2008 Jan; 85(1):112-7. PubMed ID: 18192920
[TBL] [Abstract][Full Text] [Related]
10. Fetal inoculation with donor cells in cardiac xenotransplantation.
Shen Z; Mohiuddin M; DiSesa VJ
Ann Thorac Surg; 1996 Nov; 62(5):1360-3. PubMed ID: 8893569
[TBL] [Abstract][Full Text] [Related]
11. Timing of spleen activation in rats treated with cyclophosphamide (CyP): its role in a hamster-to-rat heterotopic heart xenotransplantation (HHX) model.
Catena M; Lattanzio G; Maggiano N; Musiani P; Ferla G
Transplant Proc; 1994 Jun; 26(3):1182-3. PubMed ID: 8029878
[No Abstract] [Full Text] [Related]
12. Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate.
Hasan RI; Sriwatanawongsa V; Wallwork J; White DJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):421-2. PubMed ID: 8438362
[No Abstract] [Full Text] [Related]
13. Macrophage depletion prevents anti-graft antibody production and results in long-term survival in xenotransplantation.
Koyamada N; Sato A; Takayama J; Usuda M; Kawagishi N; Doi H; Fujimori K; Satomi S
Transplant Proc; 2005; 37(1):514-5. PubMed ID: 15808694
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
Lin Y; Sobis H; Vandeputte M; Waer M
Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
[No Abstract] [Full Text] [Related]
15. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts.
Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH
J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of immunosuppressive drugs in xenografting.
Thomas FT; DeMasi RJ; Araneda D; Marchman W; Alqaisi M; Larkin EW; Condie RM; Carobbi A; Thomas JM
Transplant Proc; 1990 Jun; 22(3):1083-5. PubMed ID: 1693452
[No Abstract] [Full Text] [Related]
17. Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model.
Yin D; Ma LL; Blinder L; Shen J; Sankary H; Williams JW; Chong AS
J Immunol; 1998 Aug; 161(4):2044-51. PubMed ID: 9712078
[TBL] [Abstract][Full Text] [Related]
18. FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy.
Schrepfer S; Deuse T; Koch-Nolte F; Krieger T; Haddad M; Schäfer H; Pelletier MP; Robbins RC; Reichenspurner H
J Heart Lung Transplant; 2007 Jan; 26(1):70-7. PubMed ID: 17234520
[TBL] [Abstract][Full Text] [Related]
19. Phase-directed therapy and cardiac xenograft survival.
Lin H; Gastman BR; Wei RQ; Kunkel SL; Gordon D; Bolling SF
J Surg Res; 1997 Sep; 72(1):84-8. PubMed ID: 9344718
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of rejection mechanisms using the splenocyte injection model in concordant xenotransplantation.
Yasutomi M; Hayashi S; Ohtsuka S; Namii Y; Ito M; Uchida K; Yokoyama I; Takagi H
Transplant Proc; 1995 Apr; 27(2):1583-4. PubMed ID: 7725417
[No Abstract] [Full Text] [Related]
[Next] [New Search]
